Galectin Therapeutics
GALT
₹94.76
Share price
-2.65%
Change (1 day)
-39.00%
Change (1 year)
Categories
Earnings for Galectin Therapeutics (GALT)
Earnings in 2024 (TTM): -₹3.77 Billion
According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -₹3.54 Billion a decrease over its 2022 earnings that were of -₹3.35 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Galectin Therapeutics from 2002 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | -₹3.77 Billion | 6.31% |
| 2023 | -₹3.54 Billion | 5.91% |
| 2022 | -₹3.35 Billion | 27.02% |
| 2021 | -₹2.63 Billion | 30.1% |
| 2020 | -₹2.03 Billion | 76.51% |
| 2019 | -₹1.15 Billion | -4.36% |
| 2018 | -₹1.2 Billion | -14.38% |
| 2017 | -₹1.4 Billion | -24.26% |
| 2016 | -₹1.85 Billion | 7.04% |
| 2015 | -₹1.73 Billion | 26.85% |
| 2014 | -₹1.37 Billion | 30.61% |
| 2013 | -₹1.05 Billion | 27.82% |
| 2012 | -₹0.82 Billion | -9.15% |
| 2011 | -₹0.9 Billion | 113.17% |
| 2010 | -₹0.43 Billion | -19.86% |
| 2009 | -₹0.53 Billion | 14.4% |
| 2008 | -₹0.46 Billion | -17.49% |
| 2007 | -₹0.56 Billion | -8.41% |
| 2006 | -₹0.61 Billion | 5.91% |
| 2005 | -₹0.58 Billion | -8.89% |
| 2004 | -₹0.63 Billion | 47.92% |
| 2003 | -₹0.43 Billion | 50.22% |
| 2002 | -₹0.29 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -₹65.89 Billion | 1,596.81% | 🇺🇸 USA |
 | ₹2.15 B | -155.54% | 🇺🇸 USA |